Co-Diagnostics, Inc. — Director's Dealing 2020

Jun 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2020-05-19

Reporting Person: SERBIN RICHARD S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-19	Common Stock	S	25000	$18.50	Disposed	0	Direct
2020-05-28	Common Stock	S	17500	$18.03	Disposed	0	Direct
2020-05-28	Common Stock	S	7500	$18.00	Disposed	0	Direct

Footnotes

F1: The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price. Therefore, the transactions occurred on the same date are placed in separate lines.